YORKTOWN HEIGHTS, NY -- (MARKET WIRE) -- September 22, 2006 -- IBM (NYSE: IBM), in collaboration with the Genome Institute of Singapore (GIS), today revealed results from a joint research study that could potentially alter our views of how cell processes are regulated.
